Both metformin and compound 991 treatment showed a trend towards a relative increase in glycolytic parameters in both cohorts (Fig. 1 B,D,F), however, this was only statistically significant for healthy control glycolysis and glycolytic capacity ( p ≤ 0.036).
← all excerpts
Substrate utilisation of cultured skeletal muscle cells in patients with CFS.
1
—
—